Vascular functions of the plasminogen activation system

被引:110
作者
Fay, William P.
Garg, Nadish
Sunkar, Madhavi
机构
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO 65212 USA
[2] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA
[3] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA
关键词
atherosclerosis; fibrinolysis; mouse; plasminogen; vascular remodeling;
D O I
10.1161/ATVBAHA.107.140046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The plasminogen activator (PA) system, which controls the formation and activity of plasmin, plays a key role in modulating hemostasis, thrombosis, and several other biological processes. While a great deal is known about the function of the PA system, it remains a focus of intensive investigation, and the list of biological pathways and human diseases that are modulated by normal and pathologic function of its components continues to lengthen. Because of remarkable advances in molecular genetics, the laboratory mouse has become the most useful animal system to study the normal and pathologic functions of the PA system. The purpose of this review is to summarize studies that have used genetically modified mice to examine the functions of the PA system in hemostasis and thrombosis, intimal hyperplasia after vascular injury, and atherosclerosis. Particular emphasis is placed on the vascular functions of PA inhibitor-1, a key regulator of the PA system, and the multiple variables that appear to account for the complex role of PA inhibitor-1 in regulating vascular remodeling. Lastly, the strengths and limitations of using mice to model human vascular disease processes are discussed.
引用
收藏
页码:1231 / 1237
页数:7
相关论文
共 86 条
  • [1] PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS
    BOOTH, NA
    SIMPSON, AJ
    CROLL, A
    BENNETT, B
    MACGREGOR, IR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) : 327 - 333
  • [2] Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma
    Broze, GJ
    Higuchi, DA
    [J]. BLOOD, 1996, 88 (10) : 3815 - 3823
  • [3] PLASMINOGEN DEFICIENCY CAUSES SEVERE THROMBOSIS BUT IS COMPATIBLE WITH DEVELOPMENT AND REPRODUCTION
    BUGGE, TH
    FLICK, MJ
    DAUGHERTY, CC
    DEGEN, JL
    [J]. GENES & DEVELOPMENT, 1995, 9 (07) : 794 - 807
  • [4] Carmeliet P, 1997, CIRC RES, V81, P829
  • [5] Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
    Carmeliet, P
    Moons, L
    Lijnen, HR
    Baes, M
    Lemaitre, V
    Tipping, P
    Drew, A
    Eeckhout, Y
    Shapiro, S
    Lupu, F
    Collen, D
    [J]. NATURE GENETICS, 1997, 17 (04) : 439 - 444
  • [6] Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation - A gene targeting and gene transfer study in mice
    Carmeliet, P
    Moons, L
    Lijnen, HR
    Janssens, S
    Lupu, F
    Collen, D
    Gerard, RD
    [J]. CIRCULATION, 1997, 96 (09) : 3180 - 3191
  • [7] Impaired arterial neointima formation in mice with disruption of the plasminogen gene
    Carmeliet, P
    Moons, L
    Ploplis, V
    Plow, E
    Collen, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) : 200 - 208
  • [8] Molecular mechanisms of fibrinolysis
    Cesarman-Maus, G
    Hajjar, KA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (03) : 307 - 321
  • [9] Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1
    Chen, Yabing
    Budd, Ralph C.
    Kelm, Robert J., Jr.
    Sobel, Burton E.
    Schneider, David J.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1777 - 1783
  • [10] Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1
    Chen, YB
    Kelm, RJ
    Budd, RC
    Sobel, BE
    Schneider, DJ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (01) : 178 - 188